There was a clear trend of decreased tumor weights at the end of study with PRGN-2009 treatment; however, there were no significant differences between treatment groups in this experiment ( Figure 2F ).
← all excerpts
Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009.
1
—
—